Microchips
Description: A contraceptive microchip that is implanted under the skin and continuously releases a progestin for as long as 16 years. It is also programmable such that the release of progestin can be turned on and off by the user or provider.

Product Details
User: Female
Hormonal: Yes
Delivery Method: Subdermal
Duration Type: Long-acting
Duration: 16 years
Regimen: - Daily release
- Daily release
Dose: 30 mcg
Active Pharmaceutical Ingredient (API): - levonorgestrel
- levonorgestrel
Multipurpose Preventive Technology (MPT): No
Status Details
Developer: Microchips Biotech, Inc.
Project Phase: Discovery and Early Development
Development Stage: Prototype Development
Began discovery in: 2013
Active Development: Yes
Status Details: - Microchips is also developing their technology for other therapeutic areas.
- Microchips is also developing their technology for other therapeutic areas.
Additional Information
References: Microchips website: http://microchipsbiotech.com/
Microchips website: http://microchipsbiotech.com/